Yazar "Dagdelen, S." için listeleme

Toplam kayıt 12, listelenen: 1-12

Volatile composition, antioxidant and antimicrobial activities of herbal plants used in the manufacture of van herby (OTLU) cheese

Dagdelen, S.; Bilenler, T.; Durmaz, G.; Gokbulut, I.; Hayaloglu, A.A.; Karabulut, I. (2014)

The aim of this study was to investigate the antioxidative, antimicrobial and aroma characteristics of the most popular herbs, with local, namely Sirmo (Allium schoenoprasum [Liliaceae]), Mendi (Chaerophyllum macropodum ...
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)

Sonmez, A.; Demirci, I.; Haymana, C.; Tasci, I.; Dagdelen, S.; Salman, S.; Ata, N.; Sahin, I.; Emral, R.; Cakal, E.; Atmaca, A.; Sahin, M.; Celik, O.; Demir, T.; Ertugrul, D.; Unluturk, U.; Caglayan, M.; Satman, I. (2021)

Background: Coronavirus disease 2019 (COVID-19) has been reported to be associated with a more severe course in patients with type 2 diabetes mellitus (T2DM). However, severe adverse outcomes are not recorded in all patients. ...
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul

Satman, I.; Demirci, I.; Haymana, C.; Tasci, I.; Salman, S.; Ata, N.; Dagdelen, S.; Sahin, I.; Emral, R.; Cakal, E.; Atmaca, A.; Sahin, M.; Celik, O.; Demir, T.; Ertugrul, D.; Unluturk, U.; Arga, K.Y.; Caglayan, M.; Sonmez, A. (2021)

Aims: Type 2 diabetes mellitus (T2DM) is a risk factor for severe COVID-19. Our aim was to compare the clinical outcomes of patients with and without T2DM during the first hit of COVID-19 in Istanbul. Methods: A retrospective ...
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia)

Haymana, C.; Demirci, I.; Tasci, I.; Cakal, E.; Salman, S.; Ertugrul, D.; Ata, N.; Unluturk, U.; Dagdelen, S.; Atmaca, A.; Sahin, M.; Celik, O.; Demir, T.; Emral, R.; Sahin, I.; Caglayan, M.; Satman, I.; Sonmez, A. (2021)

Purpose: New coronavirus disease 2019 (COVID-19) has a worse prognosis in patients with diabetes. However, there are insufficient data about the effect of hyperglycemia on COVID-19 prognosis in non-diabetic patients. This ...
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study

Emral, R.; Haymana, C.; Demirci, I.; Tasci, I.; Sahin, M.; Cakal, E.; Ata, N.; Unluturk, U.; Demir, T.; Ertugrul, D.; Sahin, I.; Atmaca, A.; Celik, O.; Caglayan, M.; Arga, K.Y.; Dagdelen, S.; Salman, S.; Satman, I.; Sonmez, A. (2021)

Introduction: To investigate the effect of preexisting treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) on COVID-19-related hospitalization and mortality in patients with type 2 diabetes mellitus (T2DM). Methods: ...
Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study (Diabetes Therapy, (2021), 12, 11, (2857-2870), 10.1007/s13300-021-01133-8)

Emral, R.; Haymana, C.; Demirci, I.; Tasci, I.; Sahin, M.; Cakal, E.; Ata, N.; Unluturk, U.; Demir, T.; Ertugrul, D.; Sahin, I.; Atmaca, A.; Celik, O.; Caglayan, M.; Arga, K.Y.; Dagdelen, S.; Salman, S.; Satman, I.; Sonmez, A. (2021)

In the Original Article, the twelfth author name was published incorrectly. The correct name is Ibrahim Sahin. The original article has been corrected. © 2021, The Author(s).
The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study

Sahin, M.; Haymana, C.; Demirci, I.; Tasci, I.; Rıfat, E.; Unluturk, U.; Satman, I.; Demir, T.; Cakal, E.; Ata, N.; Ertugrul, D.; Salman, S.; Sahin, I.; Dagdelen, S.; Celik, O.; Caglayan, M.; Atmaca, A.; Sonmez, A. (2021)

Background: There are scarce published data in differentiated thyroid cancer patients about new coronavirus disease 2019 (COVID-19) disease outcomes and mortality. Here, we evaluated COVID-19 infection outcomes and mortality ...
Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: A nationwide study

Demirci, I.; Haymana, C.; Tasci, I.; Satman, I.; Atmaca, A.; Sahin, M.; Ata, N.; Unluturk, U.; Cakal, E.; Dagdelen, S.; Sahin, I.; Celik, O.; Ertugrul, D.; Demir, T.; Emral, R.; Caglayan, M.; Salman, S.; Birinci, S.; Sonmez, A. (2022)

Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM) are lacking. The purpose of this ...
No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort study

Demirci, I.; Demir, T.; Dagdelen, S.; Haymana, C.; Tasci, I.; Atmaca, A.; Ertugrul, D.; Ata, N.; Sahin, M.; Salman, S.; Sahin, I.; Emral, R.; Unluturk, U.; Cakal, E.; Celik, O.; Caglayan, M.; Satman, I.; Sonmez, A. (2022)

Background: It is well documented that patients with chronic metabolic diseases, such as diabetes and obesity, are adversely affected by the COVID-19 pandemic. However, when the subject is rare metabolic diseases, there ...
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)

Sahin, I.; Haymana, C.; Demir, T.; Demirci, I.; Tasci, I.; Atmaca, A.; Cakal, E.; Ata, N.; Emral, R.; Unluturk, U.; Ertugrul, D.; Salman, S.; Sahin, M.; Dagdelen, S.; Celik, O.; Caglayan, M.; Satman, I.; Sonmez, A. (2022)

Purpose While obesity is related to more severe outcomes of coronavirus disease 2019 (COVID-19), factors leading to poor prognosis still remain unclear. The present study evaluated the outcomes of COVID-19 patients who ...
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

Atmaca, A.; Demirci, I.; Haymana, C.; Tasci, I.; Sahin, I.; Cakal, E.; Ata, N.; Dagdelen, S.; Salman, S.; Emral, R.; Sahin, M.; Celik, O.; Demir, T.; Ertugrul, D.; Unluturk, U.; Caglayan, M.; Satman, I.; Sonmez, A. (2022)

Summary: This study was performed to evaluate whether the use of drugs in the treatment of osteoporosis in women is associated with COVID-19 outcomes. The results showed that the risk of hospitalization, intensive care ...
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

Atmaca, A.; Demirci, I.; Haymana, C.; Tasci, I.; Sahin, I.; Cakal, E.; Ata, N.; Dagdelen, S.; Salman, S.; Emral, R.; Sahin, M.; Celik, O.; Demir, T.; Ertugrul, D.; Unluturk, U.; Caglayan, M.; Satman, I.; Sonmez, A. (2022)

Summary: This study was performed to evaluate whether the use of drugs in the treatment of osteoporosis in women is associated with COVID-19 outcomes. The results showed that the risk of hospitalization, intensive care ...

Toplam kayıt 12, listelenen: 1-12

DSpace'de Ara

Gelişmiş Arama

Göz at

Tüm DSpace

Yazar "Dagdelen, S." için listeleme

Yazar "Dagdelen, S." için listeleme

DSpace'de Ara

Göz at

Tüm DSpace

Hesabım